clinical trial sites Archives

Got a Clinical Trial Startup Post-COVID? Plan to Tackle 3 Big Challenges

There are still a lot of challenges facing pharmaceuticals, med tech, and biotech companies that seek to begin a clinical trial post-COVID. But the obstacles aren’t stopping them. At time of writing, over 500 companies have a Phase II or Phase III clinical trial startup planned in the next 12

Posted on 30 Mar 2021
By Molly Bryant
In Clinical Research Blog

A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.

The decentralized clinical trial is one of the most talked-about emerging trends in the life sciences industry. These sorts of clinical trials present immense benefits, as we wrote about in a recent blog. If executed well, the decentralized clinical trial design could both reduce resource consumption and accelerate treatments arrival to

Posted on 24 Mar 2021
By Molly Bryant
In Clinical Research Blog

Decentralized, virtual, or hybrid clinical trial – what’s the difference?

Increased diversity. Faster enrollment. Reduction in costs. These are just a few of the myriad benefits of the virtual clinical trial touted by CROs and solution providers. But are you ready for a truly virtual clinical trial? If not, is a hybrid clinical trial realistic? And what is a decentralized

Posted on 24 Mar 2021
By Molly Bryant
In Clinical Research Blog

When Seeking Diversity during Site Selection, Look Beyond Historical Data to Discover Untapped Patient Populations

We recently spoke with Liz Beatty, Chief Strategy Officer at Inato about how the company is disrupting the industry's approach to site selection. The company is headquartered in Paris, France, with US operations based in New York City, NY. Here are some of the most interesting excerpts from our discussion: ArcheMedX: You

Posted on 24 Feb 2021
By Molly Bryant
In Clinical Research Blog, Interviews

Choosing a Solution to Train Clinical Trial Site Staff Virtually? Start With this Checklist.

Choosing the right way to train clinical trial staff is complex and exhausting under normal circumstances. Today’s immense pressure to accommodate new virtual working styles across investigator meetings, site selection, and site initiation visits magnifies those challenges. As we revealed in our recent report, clinical operations leaders are adopting virtual tools

Posted on 21 Feb 2021
By Molly Bryant
In Clinical Research Blog

To Succeed with Virtual or Hybrid Clinical Trials, Listen to Patients and Sites

We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North American Operations at SCOPE International, an independent full-service CRO serving pharma, biotech, and medical device clients across the US and Europe. The company is headquartered in Mannheim, Germany, with US operations based in Pittsburgh, PA.

Posted on 10 Dec 2020
By Molly Bryant
In Clinical Research Blog, Interviews

4 Ways CROs Can Help Sponsors with Clinical Trial Readiness

When a Sponsor chooses to engage with a contract research organization (CRO), the Sponsor team expects quality and performance in return for their investment. CROs are in business to conduct trials - and offload the work from the Sponsor’s side. So why are so many trials fraught with early hiccups? The

Posted on 20 Nov 2020
By Molly Bryant
In Clinical Research Blog

The Virtual Clinical Trial Start-Up: How to Make It Work

Making it through the clinical trial start-up process is critical for any study - and takes a lot of effort under normal circumstances. But today, with the need to conduct more and more clinical operations remotely - it’s even more challenging. The good news is that there is a way forward,

Posted on 9 Sep 2020
By Molly Bryant
In Clinical Research Blog

Guessing could be adding 7 months of clinical trial delays. Here’s how to stop.

Getting new treatments approved has never been harder, but recent research reveals that the regulatory agency has also never been faster. So why is it getting more expensive and taking ever longer to bring a treatment to market? Three words: Clinical trial delays. It’s taking longer to bring a treatment to

Posted on 31 Jul 2020
By Molly Bryant
In Clinical Research Blog

Infographic: The Impact of Clinical Trial Readiness on Trial Team Performance

Implementing clinical trial readiness enables you to confidently predict who will succeed in conducting your clinical trial – and who needs more preparation.

Posted on 17 Jul 2020
By Molly Bryant
In Clinical Research Blog

Tag : clinical trial sites

Got a Clinical Trial Startup Post-COVID? Plan to Tackle 3 Big Challenges

A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.

Decentralized, virtual, or hybrid clinical trial – what’s the difference?

When Seeking Diversity during Site Selection, Look Beyond Historical Data to Discover Untapped Patient Populations

Choosing a Solution to Train Clinical Trial Site Staff Virtually? Start With this Checklist.

To Succeed with Virtual or Hybrid Clinical Trials, Listen to Patients and Sites

4 Ways CROs Can Help Sponsors with Clinical Trial Readiness

The Virtual Clinical Trial Start-Up: How to Make It Work

Guessing could be adding 7 months of clinical trial delays. Here’s how to stop.

Infographic: The Impact of Clinical Trial Readiness on Trial Team Performance

Subscribe

Request a Demo